,Rank,NCTId,Condition,BriefTitle,InterventionName,OfficialTitle,LocationCity,LocationState,LocationCountry,StartDate
0,1,NCT02509156,Cardiomyopathy Due to Anthracyclines,Stem Cell Injection in Cancer Survivors,Allo-MSCs|Placebo,"A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy",Stanford|Gainesville|Miami|Indianapolis|Louisville|Minneapolis|Houston,California|Florida|Florida|Indiana|Kentucky|Minnesota|Texas,United States|United States|United States|United States|United States|United States|United States,August 2016
